ScienTech Medical

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd., is committed to providing safe, effective, and innovative medical solutions. It is a pioneer in China's structural heart disease interventional medical device industry and a leading supplier of congenital heart disease occlusion devices in China. Focusing on the research, development, production, and marketing of interventional devices for structural heart disease treatment, the company currently has 50 products that are either on the market or under development. Its product portfolio includes a series of occluders for congenital heart disease intervention, left atrial appendage occluders and patent foramen ovale occluders for cardioembolic stroke prevention, and biointerventional valve series for treating valve stenosis and insufficiency, offering comprehensive solutions for structural heart disease intervention. The marketed products have been sold in more than 30 countries, serving over hundreds of thousands of patients cumulatively. The company boasts strong R&D capabilities and owns multiple innovative products with independent intellectual property rights, being an early participant in the research and development of bioresorbable technology. In 2009, the project "Development and Clinical Application of a Series of Occluders and Related Devices for Interventional Treatment of Defect-Related Congenital Heart Disease" won the Second Prize of the National Science and Technology Progress Award. As of the end of April 2022, the company had 228 registered patents.In the future, the company will continue to invest in R&D, constantly developing new products and technologies to benefit more patients with structural heart disease and contribute to the cause of human health.